MMP-9 metalloproteinase and its regulator are not associated with mid-term CT residual abnormalities in patients with COVID-19 pneumonia
Open Access
- 16 April 2025
- journal article
- Published by SAGE Publications in Acta Radiologica Open
- Vol. 14 (4)
Abstract
Background: COVID-19 patients may have residual pulmonary alterations after the acute disease, with fibrotic-like alterations. Since metalloproteinases (MMP) and their regulators may be involved in inflammation and abnormal repair processing, we aimed to investigate the correlations between MMP-9, a tissue inhibitor of metalloproteinases (TIMP-1) and chest CT abnormalities in acute phase and mid-term follow-up. Methods: COVID-19 patients with plasma analyses and CT scans performed at acute onset and 3 months after discharge (T post) were evaluated. MMP-9, TIMP-1, and MMP-9/TIMP-1 ratio were analyzed. CT extents of COVID-19 pneumonia and fibrotic-like alterations were visually scored (score range 0–25). Spearman rank correlation analysis ( p -value <.05) was computed between acute and mid-term plasma analyses and CT scores. Results: 39 patients were enrolled. At hospital admission, MMP-9, TIMP-1, and MMP-9/TIMP-1 had a median of 240.5 ng/mL, 258.8 ng/mL, and 0.9. The median CT global and fibrotic-like scores were 9 and 6. At T post, MMP-9 and TIMP-1 were not statistically different ( p -value <.05). There was a reduction of CT global score ( p -value = .00007). A significant correlation was found between MMP-9 and CT global score at hospital admission (ρ = 0.456, p -value = .003) and between MMP-9/TIMP-1 ratio and CT global score at hospital admission (ρ = 0.406, p -value = .009). No other significant correlations were found between plasma enzymes and CT alterations, both in acute and mid-term follow-up. Conclusion: MMP-9 plasma levels and MMP-9/TIMP-1 ratio correlate with lung involvement during the acute phase. None of the levels of MMP-9, TIMP-1, and MMP-9/TIMP-1 ratio may be adopted as predictors of residual pulmonary alterations in mid-term follow-up.Keywords
Funding Information
- Sapienza Università di Roma
This publication has 45 references indexed in Scilit:
- Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repairEuropean Respiratory Journal, 2011
- Role of metalloproteinases in platelet functionThrombosis Research, 2008
- Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury☆Human Pathology, 2006
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- Imaging in Severe Acute Respiratory Syndrome (SARS)Clinical Radiology, 2003
- Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritisArthritis & Rheumatism, 2001
- Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretionCardiovascular Research, 2001
- Matrix metalloproteinases.1997
- Matrix metalloproteinases in immunityThe Journal of Immunology, 1996
- Regulation of Tissue Inhibitor of Matrix Metalloproteinase ExpressionaAnnals of the New York Academy of Sciences, 1994